A FIXED-DOSE COMBINATION OF AMLODIPINE AND LISINOPRIL: THE ADVANTAGES OF ITS USE IN METABOLIC SYNDROME


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The authors consider the benefits of a fixed-dose combination of amlodipine and lisinopril (Ekvator, Gedeon Richter) and the advantages of its use in the treatment of obese patients with arterial hypertension. The drug provides effective blood pressure control and secondary prevention of cardiovascular events in patients with metabolic syndrome and slows the progression of atherosclerosis.

Full Text

Restricted Access

About the authors

O. Drapkina

I.M. Sechenov First Moscow State Medical University

Email: drapkina@bk.ru
Professor MD

O. Korneeva

I.M. Sechenov First Moscow State Medical University

References

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies